Literature DB >> 22473244

Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.

Po-Cheng Hung1, Huei-Shyong Wang, Ming-Liang Chou, Kuang-Lin Lin, Meng-Ying Hsieh, Alex M-C Wong.   

Abstract

The aim of this study is to describe the clinical, laboratory, and neuroimaging features, treatment and outcome of acute disseminated encephalomyelitis (ADEM) in Taiwanese children to compare with two series from United States of America and Japan. We retrospectively reviewed the medical records and magnetic resonance images of 28 children, 23 boys and 5 girls, with ADEM between January 2001 and December 2009. Their mean age at disease onset was 6 years 9 months. Twenty four children experienced a prodromal illness. There was no special seasonal distribution in our patients. They presented mostly with impaired consciousness and headache. Cerebrospinal fluid samples of 21 patients were analyzed and none showed intrathecal oligoclonal bands. Magnetic resonance imaging showed variable findings: lesions with abnormal signal changes frequently found in the subcortical white matter of frontal and parietal lobes. No patient showed cortical gray matter involvement. We also found a high rate of deep gray matter involvement including thalami and basal ganglia. Treating with steroids was usually associated with a rapid recovery and both intravenous high dose methylprednisolone and dexamethasone had the same effect. All patients survived. Twenty three patients recovered completely with only mild sequelae in the remaining five children. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22473244     DOI: 10.1055/s-0032-1309309

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

1.  A nationwide survey of pediatric acquired demyelinating syndromes in Japan.

Authors:  Y Yamaguchi; H Torisu; R Kira; Y Ishizaki; Y Sakai; M Sanefuji; T Ichiyama; A Oka; T Kishi; S Kimura; M Kubota; J Takanashi; Y Takahashi; H Tamai; J Natsume; S Hamano; S Hirabayashi; Y Maegaki; M Mizuguchi; K Minagawa; H Yoshikawa; J Kira; S Kusunoki; T Hara
Journal:  Neurology       Date:  2016-10-14       Impact factor: 9.910

Review 2.  Spinal Cord Involvement in MS and Other Demyelinating Diseases.

Authors:  Mariano Marrodan; María I Gaitán; Jorge Correale
Journal:  Biomedicines       Date:  2020-05-22

3.  Management of pediatric post-infectious neurological syndromes.

Authors:  Elena Bozzola; Giulia Spina; Massimiliano Valeriani; Laura Papetti; Fabiana Ursitti; Rino Agostiniani; Cristina Mascolo; Margherita Ruggiero; Chiara Di Camillo; Anna Quondamcarlo; Luigi Matera; Davide Vecchio; Luigi Memo; Alberto Villani
Journal:  Ital J Pediatr       Date:  2021-01-25       Impact factor: 2.638

4.  Rituximab Treatment in Acute Disseminated Encephalomyelitis Associated with Salmonella Infection.

Authors:  Ebru Kacmaz; Gurkan Bozan; Kursat Bora Carman; Omer Kilic; Mehmet Ozgur Arslanoglu; Ugur Toprak; Aslı Kavaz Tufan; Coskun Yarar; Ener Cagri Dinleyici
Journal:  Case Rep Pediatr       Date:  2021-04-17

Review 5.  COVID-19-Associated Acute Disseminated Encephalomyelitis: A Systematic Review.

Authors:  Kiran Sunil Mahapure; Anagha Sudhakar Prabhune; Aradhana Vijaysinh Chouvhan
Journal:  Asian J Neurosurg       Date:  2021-09-14

6.  Promising candidate cerebrospinal fluid biomarkers of seizure disorder, infection, inflammation, tumor, and traumatic brain injury in pediatric patients.

Authors:  Seh Hyun Kim; Soo Ahn Chae
Journal:  Clin Exp Pediatr       Date:  2021-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.